Trials / Sponsors / Exscientia AI Limited
Exscientia AI Limited
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Association of Ex Vivo Drug Response ( EVDR) and Clinical Outcome in Acute Myeloid Leukaemia (EXCYTE-2) Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia (AML) Relapse | — | 2024-05-13 |
| Terminated | Association of Ex Vivo Drug Response (EVDR) and Clinical Outcome in Ovarian Cancer Epithelial Ovarian Cancer | — | 2023-04-14 |
| Terminated | Study to Assess EXS21546 in Combination in Patients With Advanced Solid Tumours Advanced Solid Tumours | Phase 1 / Phase 2 | 2023-04-11 |
| Completed | 3-part Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EXS21546 Oncology | Phase 1 | 2020-12-08 |